Clarian buys piece of Indiana Heart Hospital
Clarian Health has acquired a controlling stake in a cardiology practice based at the Indiana Heart Hospital, which is owned
by Clarian competitor Community Health Network.
Health Care & Life Sciences
Articles
Lilly expects FDA approval of long-acting version of Zyprexa
Eli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S. Food and Drug Administration on Feb. 6.
Report sees jackpot with BioCrossroads, but expert sees obstacles
Three months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written
a report that attempts to show in detail the vast market opportunity they see.
Braly gains prestige–fast
At the beginning of 2007, few people outside WellPoint Inc. had even heard of Angela Braly. Nine months later, Fortune magazine
named her the fourth most powerful woman in business.
Taurel passes the baton
A new leader will guide the city’s largest company in 2008, with some of the biggest challenges in its history on the horizon.
Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John
C. Lechleiter, who has been the heir apparent for more than two years.
New Lilly CEO called analytical, ‘incredibly warm’
John C. Lechleiter, whom Eli Lilly and Co.’s board voted to replace Sidney Taurel as CEO, is known for getting things done
and yet also for being good at analysis and relating to people under him. Taurel will step down at the end of March but remain
chairman until the end of 2008.
Lilly’s plan to outsource more work is good news, bad news
Eli Lilly and Co. will shrink itself with “great intensity” over the next few years, in part by
outsourcing. For other local life sciences firms, that’s a fat pitch for new business. But it’s not clear if non-Lilly firms
can grow fast enough to offset the jobs and wages Indianapolis will lose from Lilly.
Clarian hospitals in Avon, Carmel turn corner after big losses
Clarian Health officials say the only way they can keep operating their medical centers downtown is to support them with profitable
suburban hospitals. So far, it seems Clarian is on the right track. As Clarian moves forward with a new, $180 million hospital
in Fishers, its two existing suburban hospitals are starting to make money.
WellPoint broadens push to improve health
WellPoint, Indiana’s largest health insurer, is making more noise than ever about what it’s doing to help improve Hoosiers’
and Americans’ health.
Lilly under gun to replace aging blockbuster Zyprexa
There’s a $2 billion hole in Eli Lilly and Co.’s future. That’s roughly how much pretax profit Lilly derives each year from
its best-seller, Zyprexa, according to calculations by IBJ. And it’s how much black ink will start running off Lilly’s books
once Zyprexa’s U.S. and European patents expire in 2011.
Angie’s List CEO wanted shot at WellPoint’s Zagat deal
WellPoint Inc. and Angie’s List are both racing to launch doctor-rating services early next year. But Angie’s List is already
sour over Well-Point’s decision to partner with New York-based Zagat Survey LLC for its doctor-rating service, apparently
without talking to Angie’s List.
WellPoint adjusts to executive exodus
Fifteen senior executives have left WellPoint Inc. since November 2004, when the giant health insurer formed through Indianapolis-based
Anthem Inc.’s $16.5 billion acquisition of California-based WellPoint Health Networks Inc. The merger made many of them rich,
work at WellPoint was grueling, and personal commitments called. So they moved on.
State feels pain from health care costs
Spending on health care is rising faster in Indiana than it is across the country. Yet the state’s job and income growth continue
to lag national norms.
Health hot spot rises in Brownsburg
Plans abound to bring new health care facilities to Brownsburg, one of Hendricks County’s fast-growing towns. Some familiar
local names, such as OrthoIndy, St. Vincent Health and Clarian Health Partners, all have claims to land in the Brownsburg
area.
Prescription drug abuse on the rise
When the Department of Justice slapped St. Vincent Indianapolis Hospital with a $1.2 million fine last month, it stunned local
medical professionals. But the issue behind St. Vincent’s troubles is no surprise. The diversion of prescriptions drugs from
the medical field into recreational use is a widespread problem in Indiana and the nation.
St. Francis CEO organizing effort to heal state’s health care
Bob Brody, CEO of St. Francis Hospital and Health Centers, is spearheading an emerging group of central Indiana health reformers
who want to start a bottom-up process to develop alternative solutions to the state’s–and possibly the nation’s–health care
crisis.
Hancock Regional Hospital retools expansion plans
Aggressive expansion plans by Indianapolis’ three biggest hospital systems have pushed Greenfield-based Hancock Regional Hospital
to change up its plans to build an outpost of physician offices in northwest Hancock County, near the borders of Marion and
Hamilton counties. But Hancock Regional isn’t backing down.
Life sciences initiative seeks to increase California ties
BioCrossroads is exploring an unusual new strategy to boost the development of Indiana’s life sciences industry: Team up with
San Diego. Advocates say it’s a novel approach with enormous potential for Indiana.
WellPoint CFO’s affairs exposed by lawsuit
In this era of hyper-scrutiny of corporate ethics, even messy personal lives can fell the career of a “well-loved and well-respected”
executive. Such appears to be the case with David C. Colby, whom WellPoint Inc. forced to resign as its vice chairman and
chief financial officer on May 30 for violating the company’s code of conduct in a “non-business” way.
Public-company CEOs lavished in perks, disclosures reveal
Seven Indiana public companies not only own corporate jets, but also let their executives use them for personal trips. Cummins
Inc., Hillenbrand Industries Inc., Zimmer Holdings Inc., Eli Lilly and Co., NiSource Inc., WellPoint Inc. and 1st Source Corp.
all allow some personal use of company jets.